Drug Shortage Report for DIFLUCAN
Report ID | 7210 |
Drug Identification Number | 02024152 |
Brand name | DIFLUCAN PWS 50MG/5ML |
Common or Proper name | DIFLUCAN |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | FLUCONAZOLE |
Strength(s) | 50MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | ORAL |
Packaging size | 100ML VIAL |
ATC code | J02AC |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-04-18 |
Estimated end date | 2017-04-21 |
Actual end date | 2017-04-20 |
Shortage status | Resolved |
Updated date | 2017-04-25 |
Company comments | Resolved Apr 20, 2017 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-04-18 | English | Compare |
v2 | 2017-04-18 | French | Compare |
v3 | 2017-04-19 | English | Compare |
v4 | 2017-04-25 | English | Compare |
v5 | 2017-04-25 | French | Compare |
Showing 1 to 5 of 5